Bio-Rad Laboratories, Inc. (BIO-B)
Market Closed
17 Jul, 20:00
NYSE NYSE Primary $
324. 98
+15.61
+5.0457%
$
8.18B Market Cap
- P/E Ratio
- Div Yield
3 Volume
11.51 Eps
$ 309.37
Previous Close Want to track BIO-B and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Bio-Rad Laboratories, Inc. (BIO-B) Statistics
Valuation metrics
Market Cap 8.18B
Enterprise value 9.1B
Trailing P/E (ttm) 49.81
Forward P/E -
PEG ratio -0.12
Price/Sales (ttm) 3.18
Price/Book (mrq) 1.2
Enterprise Value/Revenue 3.51
Enterprise Value/EBITDA 19.37
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 12
Average volume (90 days) 128
Price summary
52-Week low 244.54
52-Week high 324.98
Beta -
50-Day moving average 303.55
200-Day moving average 287.25
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio 0.2
Dividend Date -
Ex-Dividend Date -
Last split factor 2:1
Last split Date 8 Mar 2002
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.07%
Operating margin 0.09%
Operational effectiveness
Return on assets 0.02%
Return on equity 0.02%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 96.07
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 6.26
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 58.04
Total debt (mrq) -
Total Debt/Equity (mrq) 0.2
Current ratio (mrq) 3.21%
Book value per share (mrq) 254.15
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
